Ameriprise’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Buy
+3,500
New +$929K ﹤0.01% 3170
2025
Q3
Sell
-13,400
Closed -$1.21M 4199
2025
Q2
$1.21M Buy
+13,400
New +$1.06M ﹤0.01% 3182
2025
Q1
Sell
-31,400
Closed -$4.16M 4168
2024
Q4
$4.16M Buy
+31,400
New +$2.95M ﹤0.01% 2485

Other funds holding ALAB

Ameriprise's ALAB Position: Q2 2026 in Review

Ameriprise increased its Astera Labs (ALAB) stake by 35% in Q2 2026, buying an estimated $17.8M and bringing the position to 257,702 shares worth $125M. The position accounts for 0.03% of the portfolio, ranked #520.

Ameriprise first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Ameriprise held 257,702 shares of Astera Labs worth $125M as of Q2 2026.
  • Ameriprise bought 67,082 Astera Labs shares in Q2 2026, an estimated $17.8M.
  • Astera Labs made up 0.03% of Ameriprise's portfolio in Q2 2026, its #520 holding.
  • Ameriprise first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.